Abstract | CONTEXT: OBJECTIVE: This study aimed to evaluate the effect of RAI treatment on breast cancer development and recurrence among female patients with primary thyroid cancer. DESIGN: This was a retrospective cohort study. The risk of subsequent breast cancer associated with RAI and its dose in hazard ratios (HRs) with 95% confidential intervals (CIs) were calculated using time-dependent Cox proportional hazard models. PATIENTS: A total of 6150 patients with thyroid cancer enrolled between 1973 and 2009 were followed until December 2012. Of these, 3631 (59.0%) received RAI therapy. During the follow-up period, 99 primary breast cancers were diagnosed. MAIN OUTCOME MEASURE: RESULTS: RAI therapy did not significantly increase the incidence of subsequent breast cancer among female patients (hazard ratio [HR], 0.49; 95% confidence interval [CI], 0.22-1.06) when a 2-year latency period was accounted for. High-dose RAI (≥120 mCi) was associated with a reduced incidence of subsequent breast cancer (HR, 0.17; 95% CI, 0.05-0.62) in the cohort with a 2-year latency period. CONCLUSIONS: The long-term follow-up results of this study suggest that RAI treatment for patients with thyroid cancer may not increase the risk or recurrence of breast cancer.
|
Authors | Hwa Young Ahn, Hye Sook Min, Yohwan Yeo, Seung Hyun Ma, Yunji Hwang, Jee Hyun An, Hoon Sung Choi, Bhumsuk Keam, Seock-Ah Im, Do Joon Park, In Ae Park, Dong-Young Noh, Yeo-Kyu Youn, June-Key Chung, Bo Youn Cho, Sue K Park, Young Joo Park |
Journal | The Journal of clinical endocrinology and metabolism
(J Clin Endocrinol Metab)
Vol. 100
Issue 9
Pg. 3486-93
(Sep 2015)
ISSN: 1945-7197 [Electronic] United States |
PMID | 26147607
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Adult
- Breast Neoplasms
(epidemiology, etiology)
- Female
- Follow-Up Studies
- Humans
- Incidence
- Iodine Radioisotopes
(adverse effects)
- Middle Aged
- Neoplasm Recurrence, Local
(epidemiology, etiology)
- Retrospective Studies
- Thyroid Neoplasms
(radiotherapy)
|